Latest COMMODORE CAPITAL LP Stock Portfolio
$1.50Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About COMMODORE CAPITAL LP and it’s 13F Hedge Fund Stock Holdings
COMMODORE CAPITAL LP is a hedge fund based in NEW YORK, NY. On 24-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $814.6 Millions. In it's latest 13F Holdings report, COMMODORE CAPITAL LP reported an equity portfolio of $1.5 Billions as of 31 Mar, 2024.
The top stock holdings of COMMODORE CAPITAL LP are MRUS, VERA, NUVL. The fund has invested 13.1% of it's portfolio in MERUS N V and 9.1% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off RAYZEBIO INC, HARPOON THERAPEUTICS INC (HARP) and AKERO THERAPEUTICS INC (AKRO) stocks. They significantly reduced their stock positions in SAB BIOTHERAPEUTICS INC (SABS), SOLENO THERAPEUTICS INC (SLNO) and CABALETTA BIO INC (CABA). COMMODORE CAPITAL LP opened new stock positions in MIND MEDICINE MINDMED INC (MNMD), ORIC PHARMACEUTICALS INC (ORIC) and PERSPECTIVE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N V (PHVS).
The top stock holdings of COMMODORE CAPITAL LP are MRUS, VERA, NUVL. The fund has invested 13.1% of it's portfolio in MERUS N V and 9.1% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off RAYZEBIO INC, HARPOON THERAPEUTICS INC (HARP) and AKERO THERAPEUTICS INC (AKRO) stocks. They significantly reduced their stock positions in SAB BIOTHERAPEUTICS INC (SABS), SOLENO THERAPEUTICS INC (SLNO) and CABALETTA BIO INC (CABA). COMMODORE CAPITAL LP opened new stock positions in MIND MEDICINE MINDMED INC (MNMD), ORIC PHARMACEUTICALS INC (ORIC) and PERSPECTIVE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N V (PHVS).
New Buys
| Ticker | $ Bought |
|---|---|
| MIND MEDICINE MINDMED INC | 54,833,300 |
| ORIC PHARMACEUTICALS INC | 27,500,000 |
| PERSPECTIVE THERAPEUTICS INC | 25,052,600 |
| KYVERNA THERAPEUTICS INC | 22,658,800 |
| ENGENE HOLDINGS INC | 21,187,500 |
| AUTOLUS THERAPEUTICS PLC | 14,674,000 |
| NEUROGENE INC | 10,180,000 |
| ADVERUM BIOTECHNOLOGIES INC | 9,294,690 |
New stocks bought by COMMODORE CAPITAL LP
Additions
| Ticker | % Inc. |
|---|---|
| PHARVARIS N V | 7.81 |
Additions to existing portfolio by COMMODORE CAPITAL LP
Reductions
| Ticker | % Reduced |
|---|---|
| SAB BIOTHERAPEUTICS INC | -95.00 |
| SOLENO THERAPEUTICS INC | -87.89 |
| CABALETTA BIO INC | -71.05 |
| VERA THERAPEUTICS INC | -70.96 |
| RHYTHM PHARMACEUTICALS INC | -66.13 |
| IMMUNOVANT INC | -62.45 |
| VAXCYTE INC | -60.91 |
| ALPINE IMMUNE SCIENCES INC | -57.3 |
COMMODORE CAPITAL LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| HARPOON THERAPEUTICS INC | -34,110,000 |
| ADVERUM BIOTECHNOLOGIES INC | -15,056,000 |
| DYNE THERAPEUTICS INC | -23,940,000 |
| AKERO THERAPEUTICS INC | -26,385,500 |
| RAYZEBIO INC | -47,701,500 |
COMMODORE CAPITAL LP got rid off the above stocks
Current Stock Holdings of COMMODORE CAPITAL LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACET | ADICET BIO INC | 0.22 | 1,374,320 | 3,229,650 | NEW | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.62 | 657,333 | 9,294,690 | NEW | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AGLE | SPYRE THERAPEUTICS INC | 4.78 | 1,884,080 | 71,463,300 | REDUCED | -50.00 | |
| AKRO | AKERO THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ALPN | ALPINE IMMUNE SCIENCES INC | 3.64 | 1,375,000 | 54,505,000 | REDUCED | -57.3 | |
| ARVN | ARVINAS INC | 3.52 | 1,275,000 | 52,632,000 | REDUCED | -36.25 | |
| AUTL | AUTOLUS THERAPEUTICS PLC | 0.98 | 2,300,000 | 14,674,000 | NEW | ||
| CABA | CABALETTA BIO INC | 1.25 | 1,100,000 | 18,766,000 | REDUCED | -71.05 | |
| CCCC | C4 THERAPEUTICS INC | 1.86 | 3,410,380 | 27,862,800 | REDUCED | -55.13 | |
| CELC | CELCUITY INC | 2.25 | 1,555,950 | 33,608,600 | REDUCED | -55.66 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2.43 | 866,468 | 36,365,700 | REDUCED | -38.28 | |
| COGT | COGENT BIOSCIENCES INC | 2.89 | 6,425,000 | 43,176,000 | REDUCED | -42.28 | |
| DBVT | DBV TECHNOLOGIES S A | 0.00 | 92,687 | 69,432 | REDUCED | -50.00 | |
| DYN | DYNE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| HARP | HARPOON THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMVT | IMMUNOVANT INC | 1.62 | 750,990 | 24,264,500 | REDUCED | -62.45 | |
| KURA | KURA ONCOLOGY INC | 2.17 | 1,525,000 | 32,528,200 | REDUCED | -38.91 | |
| MGNX | MACROGENICS INC | 0.29 | 295,020 | 4,342,690 | NEW | ||
| MNMD | MIND MEDICINE MINDMED INC | 3.67 | 5,833,330 | 54,833,300 | NEW | ||
| MRUS | MERUS N V | 13.13 | 4,360,000 | 196,331,000 | REDUCED | -54.08 | |
| NKTX | NKARTA INC | 2.29 | 3,165,000 | 34,213,600 | REDUCED | -42.03 | |
| NUVL | NUVALENT INC | 7.47 | 1,487,760 | 111,716,000 | REDUCED | -44.11 | |
| ORIC | ORIC PHARMACEUTICALS INC | 1.84 | 2,000,000 | 27,500,000 | NEW | ||
| PCVX | VAXCYTE INC | 3.93 | 860,000 | 58,746,600 | REDUCED | -60.91 | |
| PHVS | PHARVARIS N V | 2.67 | 1,725,000 | 39,864,800 | ADDED | 7.81 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.04 | 1,050,000 | 45,496,500 | REDUCED | -66.13 | |
| SABS | SAB BIOTHERAPEUTICS INC | 0.06 | 183,174 | 831,610 | REDUCED | -95.00 | |
| SLNO | SOLENO THERAPEUTICS INC | 0.48 | 169,533 | 7,256,010 | REDUCED | -87.89 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.51 | 318,851 | 7,588,650 | NEW | ||
| THRD | THIRD HARMONIC BIO INC | 0.79 | 1,250,000 | 11,800,000 | REDUCED | -11.56 | |
| VERA | VERA THERAPEUTICS INC | 9.13 | 3,165,000 | 136,475,000 | REDUCED | -70.96 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2.27 | 1,934,650 | 33,875,800 | REDUCED | -49.73 | |
| VSTA | VISTAGEN THERAPEUTICS INC | 0.56 | 1,575,000 | 8,316,000 | REDUCED | -50.00 | |
| XENE | XENON PHARMACEUTICALS INC | 6.24 | 2,167,790 | 93,323,500 | REDUCED | -50.00 | |
| ENLIVEN THERAPEUTICS INC | 4.67 | 3,973,240 | 69,889,400 | REDUCED | -31.54 | ||
| ABIVAX SA | 1.81 | 1,895,000 | 27,098,500 | REDUCED | -50.00 | ||
| PERSPECTIVE THERAPEUTICS INC | 1.68 | 21,052,600 | 25,052,600 | NEW | |||
| KYVERNA THERAPEUTICS INC | 1.51 | 912,189 | 22,658,800 | NEW | |||
| ENGENE HOLDINGS INC | 1.42 | 1,250,000 | 21,187,500 | NEW | |||
| APOGEE THERAPEUTICS INC | 1.29 | 290,000 | 19,270,500 | REDUCED | -42.00 | ||
| NEUROGENE INC | 0.68 | 200,000 | 10,180,000 | NEW | |||
| HELIX ACQUISITION CORP II | 0.35 | 500,000 | 5,200,000 | NEW | |||
| RAYZEBIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |